Clinical Factors Predicting Tumour Upgrading in Patients Under Active Surveillance and Elected to Active Treatment after Disease Reclassification or Progression

Publisher： Karger

E-ISSN： 1423-0399|99|2|186-193

ISSN： 0042-1138

Source： Urologia Internationalis, Vol.99, Iss.2, 2017-02, pp. : 186-193

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical Factors of Disease Reclassification or Progression in a Contemporary Cohort of Prostate Cancer Patients Elected to Active Surveillance

By  

Urologia Internationalis, Vol. 98, Iss. 1, 2016-11 ,pp. : 32-39

Karger

Access to resources Recommend Favorite

Incidence of Upgrading and Upstaging in Patients with Low-Volume Gleason Score 3+4 Prostate Cancers at Biopsy: Finding a New Group Eligible for Active Surveillance

By  

Urologia Internationalis, Vol. 90, Iss. 3, 2013-02 ,pp. : 301-305

Karger

Access to resources Recommend Favorite

Sunitinib in Patients with Advanced Hepatocellular Carcinoma after Progression under Sorafenib Treatment

By  

Oncology, Vol. 79, Iss. 1-2, 2010-11 ,pp. : 85-92

Karger

Access to resources Recommend Favorite

Evaluation of a Structured Report of Functional Prostate Magnetic Resonance Imaging in Patients with Suspicion for Prostate Cancer or under Active Surveillance

By  

Urologia Internationalis, Vol. 89, Iss. 1, 2012-06 ,pp. : 25-29

Karger

Access to resources Recommend Favorite

Clinical implications of interobserver variation in assessing prostate re‐biopsies obtained during AS

By  

BJU INTERNATIONAL, Vol. 115, Iss. 4, 2015-04 ,pp. : 599-605

John Wiley & Sons Inc

Access to resources Recommend Favorite